Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma

Abstract

Baseline plasma thymus and activation-regulated chemokine levels correlate with classical Hodgkin's lymphoma tumor burden and serial levels correlate with response to treatment in patients with classical Hodgkin's lymphoma.